Ruxolitinib in treatment-naive or corticosteroid-refractory pediatric patients with chronic graft-versus-host disease: final analysis of the phase 2 REACH5 trial

Haematologica 2026 Open access

Read full text
Authors: Franco Locatelli, Bulent Antmen, Hyoung Jin Kang, Katsuyoshi Koh, Yoshiyuki Takahashi, Alphan Küpesiz, Maria Gabriela Matos, Yogi Raj Chopra, Sunil Bhat, Ho Joon Im, Tayfun Güngör, Meng‐Yao Lu
+5 more Tommaso Stefanelli, Séverine Peyrard, Yvonne S. Smith, Karen Sinclair, Cristina Díaz-de-Heredia
DOI: 10.3324/haematol.2025.300144
Cited by: 1

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Platelet Disorders and Treatments Autoimmune and Inflammatory Disorders Research

Publication details

Journal / source
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Volume
111
Issue
8
Pages
2818–2823
Publication date
19 February 2026
Language
EN